Low cholesterol linked with increase patient deaths from kidney cancer

Low cholesterol may increase kidney cancer patients’ risk of dying from their disease, according to new research. The findings, which are published in BJU International, indicate that cholesterol testing may help doctors as they monitor and treat patients with kidney cancer. Increasing evidence suggests that alterations in cholesterol and other lipids are associated with the development, progression, and prognosis of various cancers. To assess the problem as it relates to kidney cancer, Dr Tobias Klatte, of the Medical University of Vienna in Austria, and his colleagues analysed blood cholesterol levels in 867 patients with renal cell carcinoma before they underwent